David W Chow, MD
Physical Medicine and Rehabilitation · Walnut Creek
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 11
- 3 carriers
- Office
- 1
- Since medical school
- 34 years
- Northeastern Ohio University College of Medicine, 1992
On the public record
- Owns Premier Surgery Center: Accreditation Revoked
Offices
1 location · California Spine Center A Professional Medical Corporation · 3 clinicians in this group
Hospitals listed: John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plans that list them
11 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chow’s office at (925) 926-0195 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A85014 · Current
Licensed to practise in California · since 2003 · expires 2027-03-31 · Northeastern Ohio Universities College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Premier Surgery CenterAmbulatory Surgery Center · Concord, CA6% owner since 2005 · accredited by AAAHCAccreditation Revoked2 inspections, 1 with deficiencies · last 2018-10-31: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$36,804
Medicare paid this office $36,804 for 108 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (60+ min) | 34 | $6,222 | $183 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 30 | $4,784 | $117 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 16 | $4,485 | $249 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,855 | $260 |
| Return visit (30+ min) | 17 | $2,240 | $72 |
See all 12 services
| New patient visit (60+ min) | 34 | $6,222 | $183 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 30 | $4,784 | $117 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 16 | $4,485 | $249 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,855 | $260 |
| Return visit (30+ min) | 17 | $2,240 | $72 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,742 | $116 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,502 | $100 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 17 | $1,181 | $44 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 15 | $878 | $52 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 11 | $646 | $59 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $626 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 40 | $509 | $10 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 77 | 50 | 44 | 50 | 40 | 41 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 74 | 45 | 39 | 42 | 33 | 27 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 31 | 14 | – | 16 | 16 | 18 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | 12 | 11 | 17 | – | 15 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 52 | – | – | – | – | 17 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 15 | 16 | – | 17 | – | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
108 Original Medicare patients in 2024. Average age 68 · Under 65 32% · Women 61% · Also on Medicaid 36% · Health risk score 1.20. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 75% · Depression 33% · Diabetes 29% · Chronic kidney disease 24% · Coronary heart disease 19% · COPD 19% · Heart failure 18% · Cancer 14%.
The office billed $168,338, Medicare allowed $48,185 and paid $36,804; for 363 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 108 | 363 | 68 | 1.20 | $168,338 | $36,804 |
| 2023 | 188 | 1,274 | 69 | 1.52 | $395,971 | $118,960 |
| 2022 | 220 | 1,890 | 69 | 1.36 | $529,387 | $185,105 |
| 2021 | 237 | 2,110 | 69 | 1.51 | $597,408 | $221,117 |
| 2020 | 229 | 1,836 | 68 | 1.55 | $489,894 | $162,489 |
| 2019 | 260 | 2,184 | 67 | 1.47 | $755,992 | $187,793 |
| 2018 | 205 | 1,419 | 67 | 1.23 | $602,407 | $114,394 |
| 2017 | 181 | 512 | 68 | 1.52 | $199,280 | $43,748 |
| 2016 | 249 | 1,585 | 68 | 1.35 | $424,405 | $122,996 |
| 2015 | 253 | 1,951 | 70 | 1.19 | $503,885 | $142,121 |
| 2014 | 338 | 2,768 | 71 | 1.09 | $729,640 | $197,316 |
| 2013 | 398 | 3,080 | 72 | 1.14 | $928,706 | $219,800 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Return visit (30+ min) | 147 | $72,470 | $105 |
| Short return visit (20+ min) | 98 | $15,108 | $72 |
| New patient visit (60+ min) | 34 | $5,662 | $167 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 29 | $4,317 | $108 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 15 | $3,824 | $239 |
| Long return visit (40+ min) | 17 | $3,576 | $149 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 23 | $1,449 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 48 | $645 | $10 |
2022: 13 services
| Return visit (30+ min) | 187 | $117,010 | $110 |
| Short return visit (20+ min) | 100 | $18,796 | $77 |
| Long return visit (40+ min) | 66 | $12,558 | $153 |
| New patient visit (60+ min) | 42 | $8,001 | $190 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 36 | $5,487 | $110 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 15 | $3,530 | $221 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,910 | $45 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 17 | $1,841 | $108 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 17 | $1,635 | $96 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | $1,430 | $10 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 11 | $1,422 | $119 |
| Aspiration and/or injection of fluid from large joint | 11 | $1,108 | $62 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $22 | None |
2021: 11 services
| Return visit (30+ min) | 216 | $148,469 | $113 |
| Long return visit (40+ min) | 82 | $21,971 | $159 |
| Short return visit (20+ min) | 100 | $15,671 | $76 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 35 | $4,793 | $109 |
| New patient visit (60+ min) | 17 | $3,069 | $181 |
| Destruction of nerves supplying joint between spine and pelvis using imaging guidance | 14 | $2,725 | $170 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,830 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 86 | $1,567 | $11 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,296 | $118 |
| Aspiration and/or injection of fluid from large joint | 14 | $738 | $41 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 11 | $453 | $35 |
2020: 11 services
| Return visit (30+ min) | 206 | $93,194 | $94 |
| Short return visit (20+ min) | 146 | $20,687 | $69 |
| Long return visit (40+ min) | 65 | $10,429 | $124 |
| New patient visit (60+ min) | 37 | $6,487 | $175 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 40 | $5,397 | $108 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $3,724 | $266 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 30 | $2,140 | $48 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 16 | $1,461 | $91 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 81 | $1,435 | $11 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 12 | $1,331 | $111 |
| Imaging guidance for procedure, 60 minutes or less | 14 | $206 | $14 |
2019: 16 services
| Return visit (30+ min) | 233 | $93,784 | $93 |
| Long return visit (40+ min) | 179 | $36,825 | $118 |
| New patient visit (60+ min) | 91 | $15,561 | $171 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 51 | $6,915 | $90 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 21 | $6,384 | $206 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 49 | $3,641 | $32 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 47 | $3,076 | $42 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 11 | $2,823 | $202 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 22 | $2,800 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 84 | $1,664 | $10 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,426 | $95 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 12 | $1,125 | $75 |
| Aspiration and/or injection of fluid from large joint | 15 | $945 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 12 | $780 | $52 |
| Imaging guidance for procedure, 60 minutes or less | 21 | $300 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $38 | None |
2018: 13 services
| Return visit (30+ min) | 175 | $50,706 | $94 |
| Long return visit (40+ min) | 127 | $21,941 | $128 |
| New patient visit (60+ min) | 42 | $7,702 | $183 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 48 | $7,490 | $123 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 52 | $5,856 | $46 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 14 | $3,271 | $218 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 40 | $2,986 | $53 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,372 | $98 |
| Testing for presence of drug, read by direct observation | 74 | $1,359 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 77 | $1,241 | $11 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 14 | $1,219 | $58 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $765 | $55 |
| Imaging guidance for procedure, 60 minutes or less | 19 | $394 | $19 |
2017: 3 services
| Return visit (30+ min) | 161 | $29,781 | $82 |
| New patient visit (60+ min) | 35 | $5,540 | $158 |
| Long return visit (40+ min) | 31 | $3,997 | $121 |
2016: 12 services
| Return visit (30+ min) | 196 | $60,142 | $88 |
| New patient visit (60+ min) | 95 | $15,872 | $167 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 63 | $10,698 | $101 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 96 | $6,596 | $36 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 68 | $5,302 | $34 |
| Long return visit (40+ min) | 38 | $5,048 | $123 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 52 | $4,175 | $44 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $3,304 | $207 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 12 | $1,394 | $56 |
| Short return visit (20+ min) | 20 | $1,284 | $61 |
| Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (eg immunoassay) capable of being read by direct optical observation only (eg, dipsticks, cups, cards, cartridges), includes sample validation when performed, per | 17 | $277 | $15 |
| Imaging guidance for procedure, 60 minutes or less | 19 | $175 | $7 |
2015: 13 services
| Return visit (30+ min) | 223 | $73,758 | $89 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 84 | $12,910 | $103 |
| New patient visit (60+ min) | 73 | $12,763 | $175 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 88 | $9,582 | $34 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 108 | $6,681 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 72 | $5,745 | $45 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 13 | $3,054 | $235 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 13 | $1,684 | $84 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 61 | $1,532 | $19 |
| Long return visit (40+ min) | 11 | $1,295 | $118 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 13 | $873 | $46 |
| Fluoroscopic guidance for spine or back muscle injection | 11 | $313 | $26 |
| Moderate sedation services by physician or health care provider also performing a procedure | 12 | $297 | $12 |
2014: 20 services
| Return visit (30+ min) | 286 | $88,853 | $87 |
| New patient visit (60+ min) | 121 | $20,022 | $165 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 121 | $18,866 | $101 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 125 | $13,378 | $34 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 156 | $9,438 | $35 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 102 | $7,787 | $45 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 14 | $3,548 | $237 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 20 | $3,087 | $110 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 74 | $2,547 | $19 |
| Short return visit (20+ min) | 39 | $2,534 | $59 |
| Muscle electrical test | 16 | $2,147 | $83 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 19 | $1,874 | $85 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 14 | $1,626 | $86 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 11 | $1,599 | $94 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | 16 | $1,216 | $55 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 14 | $918 | $48 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 11 | $889 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 12 | $796 | $47 |
| Aspiration and/or injection of fluid from large joint | 11 | $757 | $50 |
| Moderate sedation services by physician or health care provider also performing a procedure | 24 | $715 | $12 |
2013: 26 services
| Return visit (30+ min) | 310 | $86,489 | $89 |
| New patient visit (60+ min) | 149 | $25,646 | $172 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 137 | $18,659 | $100 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 149 | $14,057 | $34 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 174 | $9,054 | $36 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 113 | $8,392 | $45 |
| Short return visit (20+ min) | 95 | $6,375 | $60 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 24 | $5,582 | $207 |
| Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter | 103 | $3,960 | $20 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 23 | $3,243 | $51 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 15 | $2,951 | $197 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 34 | $2,837 | $77 |
| New patient visit (45+ min) | 19 | $2,627 | $138 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | 18 | $2,568 | $117 |
| Muscle electrical test | 22 | $2,379 | $77 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $2,117 | $68 |
| Injection of upper or middle spine facet joint using imaging guidance, single level | 14 | $1,796 | $95 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 14 | $1,737 | $58 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,293 | $52 |
| Injection of lower or sacral spine facet joint using imaging guidance, third and any additional level | 20 | $1,205 | $46 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 20 | $1,172 | $42 |
| Injection of upper or middle spine facet joint using imaging guidance, second level | 12 | $894 | $53 |
| Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | 13 | $886 | $55 |
| Fluoroscopic guidance for spine or back muscle injection | 20 | $576 | $26 |
| Moderate sedation services by physician or health care provider also performing a procedure | 19 | $514 | $12 |
| Injection, methylprednisolone acetate, 40 mg | 15 | $43 | None |
Medicaid work
$19,878 in 2024
Medicaid paid $19,878 for 643 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 131 | $19,878 |
| Osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the SF-36, AAOS Hip & Knee Questionnaire) (OA) [Instructions: Report when osteoarthritis is addressed during the patient encounter] | 256 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 256 | $0 |
| 2024 | 643 | 3 | 27 | $19,878 |
| 2023 | 809 | 3 | 35 | $29,226 |
| 2022 | 520 | 3 | 24 | $15,304 |
| 2021 | 163 | 3 | 22 | $5,247 |
| 2020 | 119 | 4 | 15 | $2,071 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 209 | $29,226 |
| Osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the SF-36, AAOS Hip & Knee Questionnaire) (OA) [Instructions: Report when osteoarthritis is addressed during the patient encounter] | 294 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 306 | $0 |
2022
| Return visit (30+ min) | 148 | $15,304 |
| Osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the SF-36, AAOS Hip & Knee Questionnaire) (OA) [Instructions: Report when osteoarthritis is addressed during the patient encounter] | 168 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 204 | $0 |
2021
| Return visit (30+ min) | 51 | $5,247 |
| Osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the SF-36, AAOS Hip & Knee Questionnaire) (OA) [Instructions: Report when osteoarthritis is addressed during the patient encounter] | 56 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 56 | $0 |
2020
| Return visit (30+ min) | 17 | $2,071 |
| Osteoarthritis symptoms and functional status assessed (may include the use of a standardized scale or the completion of an assessment questionnaire, such as the SF-36, AAOS Hip & Knee Questionnaire) (OA) [Instructions: Report when osteoarthritis is addressed during the patient encounter] | 34 | $0 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 34 | $0 |
| Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 34 | $0 |
Drugs they prescribed that Part D paid
$5,161
Pharmacies billed $5,161 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 30% of their Part D prescriptions (32 of 108) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%. Long-acting opioids: 34% of their opioid prescriptions.
102 generic and fewer than 11 brand-name prescriptions · $5,161 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 14 | $140 | $10 |
| Ibuprofen | 11 | $118 | $11 |
Year by year
| 2024 | 108 | 46 | 30% (32) | None | $5,161 |
| 2023 | 157 | 70 | 42% (66) | 11% | $13,416 |
| 2022 | 245 | 99 | 40% (97) | 9% | $12,551 |
| 2021 | 2,465 | 281 | 52% (1,280) | 6% | $109,921 |
| 2020 | 2,610 | 276 | 54% (1,415) | 6% | $128,042 |
| 2019 | 3,284 | 294 | 65% (2,134) | 9% | $205,861 |
| 2018 | 2,466 | 214 | 68% (1,678) | 11% | $194,303 |
| 2017 | 2,701 | 220 | 68% (1,823) | 12% | $226,306 |
| 2016 | 2,005 | 216 | 66% (1,329) | 15% | $176,572 |
| 2015 | 949 | 179 | 51% (481) | None | $81,638 |
| 2014 | 1,158 | 201 | 50% (575) | None | $103,971 |
| 2013 | 1,405 | 201 | 56% (790) | None | $121,012 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Hydrocodone-Acetaminophen | 27 | $768 | $28 |
| Gabapentin | 14 | $180 | $13 |
2022: 5 drugs
| Hydrocodone-Acetaminophen | 29 | $706 | $24 |
| Oxycodone-Acetaminophen | 21 | $657 | $31 |
| Gabapentin | 18 | $452 | $25 |
| Tizanidine | 17 | $221 | $13 |
| Cyclobenzaprine | 12 | $96 | $8 |
2021: 36 drugs
| Hydrocodone-Acetaminophen | 473 | $12,904 | $27 |
| Oxycontin | 27 | $12,257 | $454 |
| Belbuca | 16 | $9,975 | $623 |
| Oxycodone-Acetaminophen | 215 | $7,296 | $34 |
| Gabapentin | 239 | $4,773 | $20 |
| Morphine Sulfate Er | 130 | $4,276 | $33 |
| Pregabalin | 99 | $3,380 | $34 |
| Lidocaine | 29 | $3,205 | $111 |
| Hydromorphone | 89 | $1,984 | $22 |
| Fentanyl | 14 | $1,841 | $132 |
| Oxycodone | 65 | $1,555 | $24 |
| Zolpidem | 50 | $1,435 | $29 |
| Morphine Sulfate | 31 | $1,169 | $38 |
| Diclofenac | 48 | $1,066 | $22 |
| Celecoxib | 25 | $1,025 | $41 |
| Tizanidine | 102 | $903 | $9 |
| Baclofen | 72 | $864 | $12 |
| Tramadol | 136 | $826 | $6 |
| Ibuprofen | 65 | $705 | $11 |
| Butalbital-Acetaminophen-Caffe | 24 | $682 | $28 |
| Trazodone | 55 | $636 | $12 |
| Cyclobenzaprine | 72 | $616 | $9 |
| Acetaminophen-Codeine | 14 | $395 | $28 |
| Methadone | 27 | $392 | $15 |
| Hydroxyzine Pamoate | 26 | $280 | $11 |
| Carisoprodol | 37 | $260 | $7 |
| Duloxetine | 22 | $219 | $10 |
| Ropinirole | 16 | $184 | $11 |
| Methocarbamol | 21 | $184 | $9 |
| Tramadol Hcl-Acetaminophen | 17 | $170 | $10 |
| Clonidine | 21 | $160 | $8 |
| Amitriptyline | 11 | $143 | $13 |
| Methylprednisolone | 19 | $143 | $8 |
| Omeprazole | 14 | $94 | $7 |
| Meloxicam | 15 | $82 | $5 |
| Diazepam | 14 | $59 | $4 |
2020: 37 drugs
| Oxycontin | 51 | $23,494 | $461 |
| Norco | 27 | $20,129 | $746 |
| Hydrocodone-Acetaminophen | 497 | $11,198 | $23 |
| Oxycodone-Acetaminophen | 245 | $10,357 | $42 |
| Nucynta | 12 | $6,696 | $558 |
| Morphine Sulfate Er | 168 | $5,240 | $31 |
| Gabapentin | 229 | $4,794 | $21 |
| Pregabalin | 78 | $3,150 | $40 |
| Oxycodone | 92 | $2,258 | $25 |
| Zolpidem | 65 | $1,946 | $30 |
| Hydromorphone | 82 | $1,567 | $19 |
| Fentanyl | 25 | $1,218 | $49 |
| Celecoxib | 25 | $1,002 | $40 |
| Tizanidine | 85 | $953 | $11 |
| Morphine Sulfate | 25 | $953 | $38 |
| Trazodone | 90 | $946 | $11 |
| Ibuprofen | 72 | $881 | $12 |
| Baclofen | 67 | $813 | $12 |
| Cyclobenzaprine | 67 | $572 | $9 |
| Tramadol | 115 | $564 | $5 |
| Eszopiclone | 13 | $513 | $39 |
| Butalbital-Acetaminophen-Caffe | 19 | $416 | $22 |
| Carisoprodol | 71 | $396 | $6 |
| Diclofenac | 13 | $335 | $26 |
| Methadone | 23 | $332 | $14 |
| Clonidine | 41 | $302 | $7 |
| Duloxetine | 14 | $287 | $21 |
| Nabumetone | 15 | $274 | $18 |
| Ropinirole | 24 | $267 | $11 |
| Methylprednisolone | 21 | $242 | $12 |
| Amitriptyline | 17 | $206 | $12 |
| Tramadol Hcl-Acetaminophen | 17 | $159 | $9 |
| Hydroxyzine Pamoate | 12 | $136 | $11 |
| Pantoprazole | 12 | $123 | $10 |
| Diazepam | 17 | $117 | $7 |
| Cephalexin | 12 | $65 | $5 |
| Omeprazole | 11 | $55 | $5 |
2019: 35 drugs
| Oxycontin | 72 | $51,941 | $721 |
| Lyrica | 44 | $24,385 | $554 |
| Hydrocodone-Acetaminophen | 809 | $18,484 | $23 |
| Norco | 23 | $15,133 | $658 |
| Morphine Sulfate Er | 305 | $13,194 | $43 |
| Oxycodone-Acetaminophen | 293 | $10,869 | $37 |
| Dilaudid | 19 | $7,267 | $382 |
| Narcan | 52 | $6,690 | $129 |
| Fentanyl | 63 | $5,243 | $83 |
| Gabapentin | 247 | $5,117 | $21 |
| Oxycodone | 155 | $4,025 | $26 |
| Zolpidem | 100 | $3,011 | $30 |
| Pregabalin | 26 | $2,962 | $114 |
| Hydromorphone | 115 | $2,697 | $23 |
| Morphine Sulfate | 50 | $2,342 | $47 |
| Oxymorphone Hcl Er | 11 | $2,150 | $195 |
| Celecoxib | 40 | $1,095 | $27 |
| Trazodone | 95 | $1,065 | $11 |
| Tramadol | 117 | $1,057 | $9 |
| Butalbital-Acetaminophen-Caffe | 22 | $964 | $44 |
| Tizanidine | 68 | $867 | $13 |
| Carisoprodol | 85 | $656 | $8 |
| Baclofen | 27 | $478 | $18 |
| Methadone | 36 | $477 | $13 |
| Duloxetine | 16 | $413 | $26 |
| Tramadol Hcl-Acetaminophen | 27 | $405 | $15 |
| Ibuprofen | 34 | $372 | $11 |
| Cyclobenzaprine | 61 | $337 | $6 |
| Acetaminophen-Codeine | 16 | $286 | $18 |
| Diazepam | 26 | $268 | $10 |
| Nabumetone | 15 | $247 | $16 |
| Omeprazole | 23 | $173 | $8 |
| Clonidine | 16 | $162 | $10 |
| Methylprednisolone | 13 | $151 | $12 |
| Hydroxyzine Pamoate | 15 | $99 | $7 |
2018: 29 drugs
| Oxycontin | 69 | $57,114 | $828 |
| Lyrica | 49 | $25,111 | $512 |
| Hydrocodone-Acetaminophen | 634 | $15,746 | $25 |
| Norco | 22 | $14,079 | $640 |
| Morphine Sulfate Er | 225 | $12,097 | $54 |
| Oxycodone-Acetaminophen | 237 | $10,793 | $46 |
| Fentanyl | 55 | $10,316 | $188 |
| Dilaudid | 22 | $7,837 | $356 |
| Hysingla Er | 12 | $6,160 | $513 |
| Gabapentin | 176 | $3,679 | $21 |
| Oxycodone | 114 | $3,096 | $27 |
| Celecoxib | 35 | $3,023 | $86 |
| Morphine Sulfate | 65 | $2,245 | $35 |
| Hydromorphone | 91 | $1,761 | $19 |
| Zolpidem | 95 | $1,358 | $14 |
| Trazodone | 56 | $703 | $13 |
| Tramadol | 55 | $689 | $13 |
| Cyclobenzaprine | 61 | $574 | $9 |
| Duloxetine | 20 | $537 | $27 |
| Tizanidine | 50 | $518 | $10 |
| Carisoprodol | 56 | $498 | $9 |
| Methadone | 24 | $367 | $15 |
| Acetaminophen-Codeine | 15 | $261 | $17 |
| Ibuprofen | 25 | $237 | $9 |
| Nabumetone | 11 | $190 | $17 |
| Methylprednisolone | 13 | $181 | $14 |
| Hydroxyzine Pamoate | 12 | $171 | $14 |
| Tramadol Hcl-Acetaminophen | 16 | $144 | $9 |
| Omeprazole | 11 | $31 | $3 |
2017: 31 drugs
| Oxycontin | 85 | $74,194 | $873 |
| Lyrica | 43 | $17,839 | $415 |
| Morphine Sulfate Er | 232 | $17,023 | $73 |
| Norco | 25 | $14,655 | $586 |
| Hydrocodone-Acetaminophen | 688 | $14,589 | $21 |
| Oxycodone-Acetaminophen | 240 | $12,698 | $53 |
| Oxymorphone Hcl Er | 18 | $7,732 | $430 |
| Fentanyl | 56 | $7,523 | $134 |
| Oxycodone | 134 | $4,464 | $33 |
| Dilaudid | 15 | $4,416 | $294 |
| Gabapentin | 199 | $4,273 | $21 |
| Oxymorphone | 13 | $3,689 | $284 |
| Morphine Sulfate | 78 | $2,866 | $37 |
| Celecoxib | 15 | $2,371 | $158 |
| Hydromorphone | 89 | $1,819 | $20 |
| Methadone | 53 | $737 | $14 |
| Trazodone | 63 | $664 | $11 |
| Diclofenac | 11 | $629 | $57 |
| Carisoprodol | 99 | $607 | $6 |
| Tramadol | 45 | $522 | $12 |
| Tizanidine | 36 | $431 | $12 |
| Butalbital-Acetaminophen-Caffe | 12 | $410 | $34 |
| Zolpidem | 70 | $392 | $6 |
| Amitriptyline | 13 | $312 | $24 |
| Cyclobenzaprine | 53 | $240 | $5 |
| Duloxetine | 13 | $216 | $17 |
| Ibuprofen | 27 | $196 | $7 |
| Tramadol Hcl-Acetaminophen | 18 | $106 | $6 |
| Alprazolam | 11 | $55 | $5 |
| Diazepam | 17 | $44 | $3 |
| Omeprazole | 11 | $30 | $3 |
2016: 28 drugs
| Oxycontin | 66 | $65,002 | $985 |
| Hydrocodone-Acetaminophen | 460 | $15,491 | $34 |
| Lyrica | 39 | $13,791 | $354 |
| Morphine Sulfate Er | 167 | $12,797 | $77 |
| Oxycodone-Acetaminophen | 168 | $9,965 | $59 |
| Fentanyl | 63 | $6,768 | $107 |
| Oxycodone | 110 | $4,215 | $38 |
| Gabapentin | 130 | $2,672 | $21 |
| Morphine Sulfate | 78 | $2,493 | $32 |
| Hydromorphone | 80 | $1,832 | $23 |
| Diclofenac | 27 | $1,699 | $63 |
| Zolpidem | 67 | $953 | $14 |
| Methadone | 42 | $867 | $21 |
| Butalbital-Acetaminophen-Caffe | 11 | $691 | $63 |
| Lorazepam | 18 | $589 | $33 |
| Carisoprodol | 76 | $474 | $6 |
| Tramadol | 38 | $430 | $11 |
| Acetaminophen-Codeine | 11 | $385 | $35 |
| Duloxetine | 14 | $295 | $21 |
| Baclofen | 17 | $211 | $12 |
| Tramadol Hcl-Acetaminophen | 18 | $209 | $12 |
| Diazepam | 42 | $208 | $5 |
| Tizanidine | 18 | $202 | $11 |
| Trazodone | 27 | $174 | $6 |
| Ibuprofen | 18 | $144 | $8 |
| Cyclobenzaprine | 21 | $91 | $4 |
| Temazepam | 12 | $83 | $7 |
| Pantoprazole | 12 | $79 | $7 |
2015: 23 drugs
| Oxycontin | 25 | $16,430 | $657 |
| Hydrocodone-Acetaminophen | 173 | $5,991 | $35 |
| Oxycodone-Acetaminophen | 71 | $5,344 | $75 |
| Intermezzo | 13 | $5,004 | $385 |
| Lyrica | 16 | $4,872 | $304 |
| Morphine Sulfate Er | 34 | $4,558 | $134 |
| Fentanyl | 30 | $3,752 | $125 |
| Gabapentin | 82 | $2,518 | $31 |
| Dextroamphetamine Sulfate | 11 | $1,951 | $177 |
| Oxycodone | 47 | $1,603 | $34 |
| Lorazepam | 17 | $529 | $31 |
| Zolpidem | 42 | $467 | $11 |
| Morphine Sulfate | 21 | $434 | $21 |
| Baclofen | 22 | $433 | $20 |
| Carisoprodol | 38 | $350 | $9 |
| Hydromorphone | 22 | $313 | $14 |
| Methadone | 20 | $298 | $15 |
| Diclofenac | 13 | $271 | $21 |
| Cyclobenzaprine | 13 | $262 | $20 |
| Alprazolam | 30 | $146 | $5 |
| Tramadol | 19 | $94 | $5 |
| Meloxicam | 14 | $63 | $4 |
| Clonazepam | 11 | $57 | $5 |
2014: 28 drugs
| Oxycontin | 38 | $19,020 | $501 |
| Lidocaine | 22 | $7,365 | $335 |
| Hydrocodone-Acetaminophen | 249 | $5,697 | $23 |
| Lyrica | 18 | $5,561 | $309 |
| Oxycodone-Acetaminophen | 57 | $5,012 | $88 |
| Fentanyl | 34 | $4,380 | $129 |
| Duloxetine | 17 | $3,687 | $217 |
| Morphine Sulfate Er | 32 | $3,188 | $100 |
| Celebrex | 14 | $2,808 | $201 |
| Oxycodone | 48 | $2,509 | $52 |
| Gabapentin | 102 | $1,831 | $18 |
| Voltaren | 12 | $1,473 | $123 |
| Carisoprodol | 49 | $845 | $17 |
| Hydromorphone | 23 | $574 | $25 |
| Morphine Sulfate | 33 | $486 | $15 |
| Baclofen | 22 | $463 | $21 |
| Zolpidem | 40 | $340 | $8 |
| Lorazepam | 21 | $319 | $15 |
| Methocarbamol | 16 | $267 | $17 |
| Methylprednisolone | 11 | $248 | $23 |
| Cyclobenzaprine | 18 | $209 | $12 |
| Ibuprofen | 21 | $193 | $9 |
| Tramadol | 22 | $182 | $8 |
| Diazepam | 18 | $177 | $10 |
| Alprazolam | 24 | $154 | $6 |
| Methadone | 14 | $149 | $11 |
| Pantoprazole | 15 | $148 | $10 |
| Ropinirole | 12 | $122 | $10 |
2013: 27 drugs
| Oxycontin | 51 | $22,269 | $437 |
| Opana Er | 26 | $13,789 | $530 |
| Lidoderm | 20 | $9,598 | $480 |
| Hydrocodone-Acetaminophen | 379 | $8,061 | $21 |
| Fentanyl | 38 | $6,262 | $165 |
| Oxycodone Hcl-Acetaminophen | 81 | $4,700 | $58 |
| Lyrica | 17 | $4,224 | $248 |
| Morphine Sulfate Er | 47 | $4,091 | $87 |
| Celebrex | 15 | $2,844 | $190 |
| Cymbalta | 13 | $2,751 | $212 |
| Oxycodone | 41 | $1,810 | $44 |
| Butrans | 11 | $1,639 | $149 |
| Hydromorphone | 24 | $1,174 | $49 |
| Gabapentin | 71 | $1,163 | $16 |
| Carisoprodol | 75 | $1,118 | $15 |
| Tizanidine | 48 | $826 | $17 |
| Morphine Sulfate | 32 | $715 | $22 |
| Methylprednisolone | 24 | $568 | $24 |
| Tramadol Hcl-Acetaminophen | 18 | $489 | $27 |
| Methadone | 26 | $332 | $13 |
| Zolpidem | 48 | $306 | $6 |
| Methocarbamol | 18 | $245 | $14 |
| Cyclobenzaprine | 19 | $186 | $10 |
| Diazepam | 29 | $143 | $5 |
| Alprazolam | 19 | $138 | $7 |
| Ibuprofen | 19 | $131 | $7 |
| Omeprazole | 12 | $113 | $9 |
Money from drug and device companies
$487 in 2025
| 2025 | 8 | 15 | None | $487 |
| 2024 | 5 | 13 | None | $420 |
| 2023 | 13 | 31 | None | $1,271 |
| 2022 | 15 | 30 | None | $627 |
| 2021 | 10 | 37 | None | $588 |
| 2020 | 13 | 44 | $500 | $1,215 |
| 2019 | 17 | 93 | None | $1,664 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | General - Pain Management | $188 | 4 payments
|
| Saluda Medical Americas | Evoke | $123 | 4 payments
|
| Collegium Pharmaceutical | Belbuca | $39 | 2 payments
|
| Vertex Pharmaceuticals | Journavx | $35 | 1 payment
|
| Abbott Laboratories | Eterna | $30 | 1 payment
|
| Globus Medical | Senza | $27 | 1 payment
|
See all 15 published payments
| Globus Medical | Meals · 2025-12-22 | Senza | $27 |
| Collegium Pharmaceutical | Meals · 2025-12-19 | Belbuca | $22 |
| Abbott Laboratories | Meals · 2025-10-17 | Eterna | $30 |
| Boston Scientific | Meals · 2025-09-19 | General - Pain Management | $68 |
| Boston Scientific | Meals · 2025-09-18 | General - Pain Management | $104 |
| Boston Scientific | Meals · 2025-08-18 | Wavewriter Alpha Prime 16 | $5 |
| Boston Scientific | Meals · 2025-08-05 | Wavewriter Alpha Prime 16 | $12 |
| Collegium Pharmaceutical | Meals · 2025-04-22 | Belbuca | $16 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-14 | Relistor | $23 |
| Saluda Medical Americas | Meals · 2025-04-10 | Evoke | $44 |
| Vertex Pharmaceuticals | Meals · 2025-03-28 | Journavx | $35 |
| Saluda Medical Americas | Meals · 2025-02-20 | Evoke | $24 |
| Saluda Medical Americas | Meals · 2025-02-19 | Evoke | $23 |
| Ermi | Meals · 2025-02-07 | None | $22 |
| Saluda Medical Americas | Meals · 2025-01-07 | Evoke | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $420
| Boston Scientific | Wavewriter Alpha Prime 16 | $226 | 6 payments
|
| Biotronik Nro | Prospera | $79 | 2 payments
|
| Nevro | Senza | $64 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $33 | 2 payments
|
| Si-Bone | None | $19 | 1 payment
|
2023: $1,271
| Boston Scientific | Wavewriter Alpha Prime 16 | $494 | 10 payments
|
| Painteq | Painteq | $189 | 2 payments
|
| Nevro | Senza | $160 | 6 payments
|
| Vertos Medical | Mild Device Kit | $86 | 1 payment
|
| Abbott Laboratories | Proclaim | $68 | 1 payment
|
| Saluda Medical Americas | Evoke Scs | $57 | 1 payment
|
| Relievant Medsystems | Intracept | $51 | 2 payments
|
| Si-Bone | None | $40 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $31 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $29 | 2 payments
|
| RedHill Biopharma | None | $24 | 1 payment
|
| Pacira Pharmaceuticals | Iovera | $23 | 1 payment
|
| Stratus Medical | Nimbus | $18 | 1 payment
|
2022: $627
| Nalu Medical | Nalu Neurostimulation System | $106 | 4 payments
|
| Boston Scientific | General - Pain Management | $67 | 3 payments
|
| Nevro | Omnia | $64 | 2 payments
|
| Vertos Medical | Mild Device Kit | $59 | 1 payment
|
| Abbott Laboratories | Proclaim | $58 | 3 payments
|
| Collegium Pharmaceutical | Xtampza | $52 | 3 payments
|
| Painteq | Painteq | $47 | 1 payment
|
| RedHill Biopharma | Talicia | $42 | 2 payments
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W/Receiver | $29 | 4 payments
|
| Forte Bio-Pharma | Prolate | $25 | 1 payment
|
| Si-Bone | None | $19 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $18 | 1 payment
|
| Athena Bioscience | Qdolo | $16 | 1 payment
|
| IBSA Pharma | Tirosint | $13 | 1 payment
|
| Azurity Pharmaceuticals | Horizant | $12 | 1 payment
|
2021: $588
| Collegium Pharmaceutical | Xtampza | $157 | 12 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $128 | 8 payments
|
| Forte Bio-Pharma | Prolate | $107 | 1 payment
|
| Boston Scientific | Superion | $52 | 2 payments
|
| Abbott Laboratories | Proclaim Ipg | $33 | 1 payment
|
| Stimwave Technologies | Stimq Receiver Stimulator Kit Channel A US W Receiver | $31 | 1 payment
|
| Bioventus | Gelsyn-3 | $29 | 1 payment
|
| Medtronic | Intellis | $21 | 1 payment
|
| Xeris Pharmaceuticals | Keveyis | $17 | 1 payment
|
| IBSA Pharma | Licart | $14 | 1 payment
|
2020: $1,215
| US WorldMeds | Lucemyra/Lofexidine | $557 | 6 payments
|
| Boston Scientific | General - Pain Management | $140 | 7 payments
|
| Collegium Pharmaceutical | Xtampza | $126 | 13 payments
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $87 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $63 | 4 payments
|
| Medtronic USA | Kyphon Balloon Kyphoplasty | $45 | 3 payments
|
| Biodelivery Sciences International | Belbuca | $45 | 3 payments
|
| Bioventus | Gelsyn 3 | $39 | 1 payment
|
| Electronic Waveform Lab | None | $36 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $23 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $21 | 1 payment
|
| Avanos Medical | Generator | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Movantik | $15 | 1 payment
|
2019: $1,664
| SPR Therapeutics | Sprint Pns System | $327 | 5 payments
|
| US WorldMeds | Lucemyra/Lofexidine | $192 | 10 payments
|
| Avanos Medical | Coolief* Cooled Radiofrequency | $159 | 3 payments
|
| Arbor Pharmaceuticals | Horizant | $145 | 15 payments
|
| Boston Scientific | Spectra Wavewriter | $138 | 2 payments
|
| Collegium Pharmaceutical | Xtampza | $112 | 27 payments
|
| Bausch Health US | Migranal | $89 | 5 payments
|
| Electronic Waveform Lab | None | $88 | 4 payments
|
| Assertio Therapeutics | Gralise | $86 | 4 payments
|
| Daiichi Sankyo | Morphabond Er | $84 | 4 payments
|
| Nevro | Senza Spinal Cord Stimulation System | $81 | 1 payment
|
| Pfizer | Lyrica | $51 | 3 payments
|
| Smith+Nephew | Pico 7 Single Use Negative Pressure Wound Therapy | $31 | 1 payment
|
| Medtronic USA | Kyphon Balloon Kyphoplasty | $31 | 1 payment
|
| Vertiflex | Superion Iss | $19 | 1 payment
|
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Movantik | $13 | 1 payment
|
Professional record
- NPI
- 1700823762
- Licence
- CA A85014California A85014: Current · expires 2027-03-31
- Trained
- Northeastern Ohio University College of Medicine, 1992 · 34 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 2123 Ygnacio Valley Road, Building K, Suite 200, Walnut Creek, CA, 94598
- NPI first listed
- 2006-05-31
- NPI last updated
- 2012-07-30
This is when the NPI record was last certified, not a medical board exam.